The European Union cannot jeopardise patient access to generic medicines through the Urban Wastewater Treatment Directive

Medicines for Europe is deeply concerned about the Extended Producer Responsibility (EPR) system in the Urban Wastewater Treatment Directive under discussion in trilogue negotiations.

Open

European Parliament report on the Urban Wastewater Treatment… 20 September 2023 The European Parliament ENVI Committee voted today to ensure that…
Proposals on wastewater treatment will jeopardise patient… 26 October 2022 Medicines have a unique value to public health and society…
Final recommendations from "Ensuring equitable and… 17 November 2022 Medicines for Europe, the European off-patent medicines association, and CAFF,…
Access to medicines and security of supply should be central… 13 June 2023 Generic and biosimilar medicines significantly lower healthcare treatment costs and…

The European Union cannot jeopardise patient access to generic medicines through the Urban Wastewater Treatment Directive

8 January 2024

Related Posts